1. Home
  2. HE vs LMAT Comparison

HE vs LMAT Comparison

Compare HE & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hawaiian Electric Industries Inc.

HE

Hawaiian Electric Industries Inc.

HOLD

Current Price

$15.08

Market Cap

2.7B

Sector

Utilities

ML Signal

HOLD

Logo LeMaitre Vascular Inc.

LMAT

LeMaitre Vascular Inc.

HOLD

Current Price

$111.81

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HE
LMAT
Founded
1891
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Electric Utilities: Central
Medical/Dental Instruments
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.6B
IPO Year
1994
2006

Fundamental Metrics

Financial Performance
Metric
HE
LMAT
Price
$15.08
$111.81
Analyst Decision
Sell
Buy
Analyst Count
2
5
Target Price
$13.25
$105.80
AVG Volume (30 Days)
1.3M
143.7K
Earning Date
05-08-2026
05-05-2026
Dividend Yield
N/A
0.87%
EPS Growth
106.32
30.57
EPS
0.71
2.52
Revenue
$3,086,896,000.00
$249,602,000.00
Revenue This Year
$7.00
$14.21
Revenue Next Year
$4.06
$8.88
P/E Ratio
$21.66
$45.48
Revenue Growth
N/A
13.53
52 Week Low
$10.08
$78.01
52 Week High
$17.33
$118.01

Technical Indicators

Market Signals
Indicator
HE
LMAT
Relative Strength Index (RSI) 45.47 52.51
Support Level $15.06 $81.60
Resistance Level $16.05 $113.40
Average True Range (ATR) 0.44 2.88
MACD -0.04 -0.49
Stochastic Oscillator 12.27 21.35

Price Performance

Historical Comparison
HE
LMAT

About HE Hawaiian Electric Industries Inc.

Hawaiian Electric Industries is the parent company of three Hawaii-based regulated utilities and owns a 10% minority interest in Hawaii's American Savings Bank. The utilities provide electricity on the five islands of Oahu, Hawaii, Maui, Molokai, and Lanai.

About LMAT LeMaitre Vascular Inc.

LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.

Share on Social Networks: